Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 111701-111750 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03003117
The prEgnanCy and eArly Childhood nutrItion triaL (ECAIL)
NA
Recruiting
800 participants
Started: Apr 3, 2017 · Completed: Dec 31, 2027
5 conditions
6 sponsors
2 locations
NCT03099434
Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media
NA
Active, not recruiting
775 participants
Started: Apr 1, 2017 · Completed: Dec 7, 2025
2 conditions
4 sponsors
2 locations
NCT03018132
Preeclampsia Research on Vitamin D, Inflammation, & Depression
NA
Active, not recruiting
200 participants
Started: Apr 1, 2017 · Completed: Jul 31, 2025
4 conditions
2 sponsors
1 location
NCT03269981
Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer
NA
Active, not recruiting
827 participants
Started: Apr 1, 2017 · Completed: Dec 30, 2029
1 condition
3 sponsors
1 location
NCT04318769
An Affirmative Coping Skills Intervention to Improve Mental and Sexual Health of Sexual and Gender Minority Youth
NA
Active, not recruiting
300 participants
Started: Apr 1, 2017 · Completed: Dec 31, 2025
4 conditions
1 sponsor
7 locations
NCT03077061
Peri-implantitis - Reconstructive Surgical Therapy
NA
Active, not recruiting
140 participants
Started: Apr 1, 2017 · Completed: Mar 14, 2026
1 condition
2 sponsors
1 location
NCT03081390
Migraine and CVD Risk in Women
NA
Active, not recruiting
30 participants
Started: Apr 1, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
2 locations
NCT05382585
Newer Therapeutic Targets in Head and Neck Cancers
N/A
Recruiting
200 participants
Started: Apr 1, 2017 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT03775577
Exercise Intolerance in Heart Failure
N/A
Recruiting
130 participants
Started: Apr 1, 2017 · Completed: Aug 31, 2027
1 condition
2 sponsors
1 location
NCT03593148
The Effect of Lifestyle Treatment in Patients With Morbid Obesity
NA
Recruiting
600 participants
Started: Apr 1, 2017 · Completed: Dec 23, 2025
4 conditions
2 sponsors
1 location
NCT03245242
Pediatric Urology Recovery After Surgery Endeavor (PURSUE)
N/A
Active, not recruiting
85 participants
Started: Apr 1, 2017 · Completed: Oct 31, 2025
3 conditions
1 sponsor
7 locations
NCT03051282
Genetic Determinants of ACEI Prodrug Activation
PHASE4
Recruiting
30 participants
Started: Apr 1, 2017 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT03305861
Green LEP vs ThuLEP in Management of Marked Enlarged Prostate
NA
Recruiting
110 participants
Started: Apr 1, 2017 · Completed: Nov 1, 2024
1 condition
1 sponsor
1 location
NCT03618485
Registry of Patients With MPNs in Taiwan
N/A
Active, not recruiting
500 participants
Started: Apr 1, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03343873
The Effects of Different Anesthetics on Functional Connectivity
NA
Recruiting
240 participants
Started: Apr 1, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03124212
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
N/A
Recruiting
700 participants
Started: Apr 1, 2017 · Completed: Sep 30, 2027
2 conditions
4 sponsors
9 locations
NCT03704532
Nonoperative Treatment of Acute Achilles Tendor Rupture
N/A
Active, not recruiting
200 participants
Started: Apr 1, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03256266
Effect of Antigens or Therapeutic Agents on in Vitro Human Intestinal Organoids
N/A
Active, not recruiting
375 participants
Started: Apr 1, 2017 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT03097939
Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
PHASE2
Recruiting
113 participants
Started: Mar 31, 2017 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT03192267
Early Rheumatoid Arthritis Lung Disease Study
N/A
Recruiting
100 participants
Started: Mar 31, 2017 · Completed: Mar 31, 2029
1 condition
1 sponsor
1 location
NCT03012100
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
PHASE2
Active, not recruiting
280 participants
Started: Mar 31, 2017 · Completed: Jul 31, 2026
12 conditions
2 sponsors
12 locations
NCT03106324
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
N/A
Active, not recruiting
911 participants
Started: Mar 31, 2017 · Completed: Jan 13, 2026
1 condition
1 sponsor
125 locations
NCT03016741
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
PHASE4
Active, not recruiting
100 participants
Started: Mar 31, 2017 · Completed: Aug 31, 2029
5 conditions
1 sponsor
5 locations
NCT03242382
Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.
PHASE2
Recruiting
40 participants
Started: Mar 31, 2017 · Completed: Sep 30, 2024
3 conditions
1 sponsor
19 locations
NCT03107533
Scoliosis Shared Decision Making
N/A
Recruiting
25 participants
Started: Mar 30, 2017 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT03060057
"Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - U-Propel Study"
N/A
Active, not recruiting
200 participants
Started: Mar 30, 2017 · Completed: Mar 30, 2026
1 condition
1 sponsor
4 locations
NCT02849496
Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer
PHASE2
Active, not recruiting
81 participants
Started: Mar 30, 2017 · Completed: Aug 31, 2026
4 conditions
1 sponsor
58 locations
NCT03094429
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
PHASE2/PHASE3
Recruiting
287 participants
Started: Mar 29, 2017 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03026140
Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
PHASE2
Recruiting
353 participants
Started: Mar 29, 2017 · Completed: Mar 1, 2032
1 condition
2 sponsors
6 locations
NCT03154346
Project Baseline Health Study
N/A
Active, not recruiting
10,000 participants
Started: Mar 29, 2017 · Completed: Dec 31, 2024
1 condition
5 sponsors
5 locations
NCT03238378
Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours
NA
Recruiting
96 participants
Started: Mar 29, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03129854
Androgen Deprivation Therapy (ADT) Versus ADT Plus Prostate Cryotherapy for Metastatic Prostate Cancer (mPCa)
NA
Recruiting
250 participants
Started: Mar 29, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05397262
Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
NA
Recruiting
1,000 participants
Started: Mar 29, 2017 · Completed: Dec 31, 2099
1 condition
1 sponsor
1 location
NCT03117751
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
PHASE2/PHASE3
Active, not recruiting
790 participants
Started: Mar 29, 2017 · Completed: Sep 30, 2028
2 conditions
4 sponsors
8 locations
NCT03082534
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
PHASE2
Active, not recruiting
78 participants
Started: Mar 28, 2017 · Completed: May 31, 2026
12 conditions
2 sponsors
4 locations
NCT03478670
Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)
N/A
Enrolling by invitation
50 participants
Started: Mar 28, 2017 · Completed: May 31, 2037
1 condition
1 sponsor
1 location
NCT02784119
APCext : Effect of Temporary Porto-caval Shunt During Liver Transplantation on Function of Liver Graft From Extended Criteria Donor
NA
Recruiting
214 participants
Started: Mar 28, 2017 · Completed: Jul 31, 2025
1 condition
1 sponsor
6 locations
NCT03057106
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
PHASE2
Active, not recruiting
301 participants
Started: Mar 28, 2017 · Completed: Dec 30, 2025
1 condition
4 sponsors
49 locations
NCT02897427
Throat and Other HPV-Related Cancers in Men: Identifying Them Early
N/A
Active, not recruiting
1,500 participants
Started: Mar 28, 2017 · Completed: Mar 28, 2027
1 condition
3 sponsors
1 location
NCT02923011
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
PHASE3
Recruiting
56 participants
Started: Mar 28, 2017 · Completed: Jun 30, 2025
1 condition
2 sponsors
3 locations
NCT02788981
Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
PHASE2
Active, not recruiting
29 participants
Started: Mar 28, 2017 · Completed: Aug 31, 2026
1 condition
1 sponsor
5 locations
NCT03231150
Plantar Fasciitis Randomized Clinical Control Trial
NA
Recruiting
62 participants
Started: Mar 28, 2017 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT02890953
Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)
PHASE2
Active, not recruiting
22 participants
Started: Mar 28, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02932007
Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
PHASE2
Recruiting
40 participants
Started: Mar 28, 2017 · Completed: Sep 30, 2020
1 condition
1 sponsor
1 location
NCT02967289
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting
PHASE3
Active, not recruiting
792 participants
Started: Mar 27, 2017 · Completed: Jun 30, 2027
1 condition
3 sponsors
17 locations
NCT03115840
Measuring Outcomes of Activity in Intensive Care
N/A
Active, not recruiting
312 participants
Started: Mar 27, 2017 · Completed: Dec 31, 2025
7 conditions
2 sponsors
2 locations
NCT03108001
Glowing and Expecting Follow Up
N/A
Recruiting
514 participants
Started: Mar 27, 2017 · Completed: Mar 1, 2031
1 condition
1 sponsor
1 location
NCT03043872
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)
PHASE3
Active, not recruiting
987 participants
Started: Mar 27, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
207 locations
NCT03162549
CorEvitas Inflammatory Bowel Disease (IBD) Registry
N/A
Enrolling by invitation
2,287 participants
Started: Mar 27, 2017 · Completed: Dec 31, 2100
1 condition
1 sponsor
1 location
NCT02915120
Ultrasound-Guided Pulsed Radiofrequency In The Treatment Of Patients With Osteoarthritis Knee (USPRFGENOAK)
NA
Recruiting
142 participants
Started: Mar 27, 2017 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
Previous
1
More pages
2232
2233
2234
2235
2236
2237
2238
More pages
2369
Next